IL7 and HIV infectious disease: Despite minimally affecting T cell activation, both IL-7 and CCL19 treatment led to an increase in HIV infection compared to untreated resting CD4+ T cells (Fig 1C and 1D), suggesting that the permissibility of resting CD4+ T cells can be enhanced without undergoing classic T cell activation, which agrees with previous studies [47, 49].